Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Tested SARS- CoV-2 positive within last 8 days of study enrolment. Patients willing to sign written informed consent and are ready to comply to study procedure. SARS-CoV-2 positive asymptomatic or symptomatic patients who are under institutional quarantine/ home isolated/ hospitalized.
Exclusion criteria
Exclusion criteria: Patients on ventilator support. Pregnant or lactating woman. Subjects with history of sun burn on hands. Subjects with history of skin disorders or on medication for the same: Eczema, Urticaria, Psoriasis, Herpes, skin cancer, Lupus, Vitiligo, Fungal infection, Candidiasis. Subjects on treatment of any degree burns. Any kind of psychiatric disorder or a condition in the opinion of the investigator may hinder communication with the research team. Inability of the subject to cooperate or communicate with the research team and provide follow up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinically significant Quantitative Reduction of 80% Virus load from baseline to EOT.Timepoint: 90 sec | — |
Secondary
| Measure | Time frame |
|---|---|
| Tolerability and safety of interventionTimepoint: 90 sec | — |
Countries
India
Contacts
MIYAKAWA KOGYO INDIA PVT LTD